These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5093996)

  • 1. Activation of coagulation by heparin-protamine complexes as demonstrated by thrombotest.
    Godal HC; Gjengedal G
    Scand J Haematol; 1971; 8(3):194-9. PubMed ID: 5093996
    [No Abstract]   [Full Text] [Related]  

  • 2. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition of heparin effects by protamine sulfate].
    GERENDAS M
    Orv Hetil; 1956 Jan; 97(5):113-8. PubMed ID: 13335127
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 6. Interaction studies with metolazone, heparin and protamine sulfate.
    Yelnosky J; Borrelli A; Kaiser F; Belair E
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):5-11. PubMed ID: 4746632
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of heparin and protamine in presence of overdosage: in vitro study.
    Hanke AA; Severloh I; Flöricke F; Weber CF; Lang T
    Asian Cardiovasc Thorac Ann; 2021 Jan; 29(1):5-9. PubMed ID: 32854516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic derivative of dextran reverses anticoagulant activity of unfractionated heparin in animal models of arterial and venous thrombosis.
    Kalaska B; Sokolowska E; Kaminski K; Szczubialka K; Kramkowski K; Mogielnicki A; Nowakowska M; Buczko W
    Eur J Pharmacol; 2012 Jul; 686(1-3):81-9. PubMed ID: 22579410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies of heparin-protamine activity with special reference to protamine inhibition of clotting.
    ANDERSEN MN; MENDELOW M; ALFANO GA
    Surgery; 1959 Dec; 46():1060-8. PubMed ID: 13793331
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study.
    Mittermayr M; Margreiter J; Velik-Salchner C; Klingler A; Streif W; Fries D; Innerhofer P
    Br J Anaesth; 2005 Sep; 95(3):310-6. PubMed ID: 16024582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is protamine a clinically important anticoagulant? A negative answer.
    Ellison N; Ominsky AJ; Wollman H
    Anesthesiology; 1971 Dec; 35(6):621-9. PubMed ID: 5124742
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of anticoagulant drugs in vascular thrombosis: electron microscopic and biophysical study.
    Sawyer PN; Stanczewski B; Pomerance A; Stoner G; Srinivasan S
    Surgery; 1973 Aug; 74(2):263-75. PubMed ID: 4717662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.